Cancer Cachexia Market Report 2023-2028 PDF | Growth | Trends | Forecast

1. Cancer Cachexia Market Report 2023 By Therapeutics, Mode Of Action and Distribution Channel Key Regions and Competitive Landscape www.imarcgroup.com Sales@imarcgroup.com +1-631-791-1145 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value challenges, and transform their businesses. opportunities, address their most critical IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. industrial, and high technology IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Cancer Cachexia Market Outlook 2023-2028: The global cancer cachexia market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4.5% during 2023-2028. Cancer cachexia is a complex and multifactorial syndrome characterized by the loss of skeletal muscle mass, asthenia, negative protein balance, loss of appetite, and anemia. It shows symptoms of decreased secretion of host anabolic hormones and abnormalities in protein, lipid, and carbohydrate metabolism. It is divided into three stages, which include pre-cachexia, cachexia, and refractory cachexia. It generally occurs in patients with pancreatic and lung cancer, tuberculosis (TB), chronic renal failure, obstructive pulmonary disease (COPD), and human immunodeficiency virus (HIV). It can be treated with combination therapy and various approaches, including diet modification, nutritional supplements, adapted exercise, and medications that decrease inflammation.

4. Report Description and Highlights Report Description Global Cancer Cachexia Market Trends: At present, the rising prevalence of liver, lung, pancreatic, and other cancers, along with the increasing aging population, is catalyzing the demand for medications and therapies to prevent cancer cachexia. In addition, the growing awareness among the masses about the benefits of early diagnosis and the availability of novel therapeutic drugs to prevent the severity of cancer is positively influencing the market. Apart from this, the introduction of numerous nutritional and appetite stimulants, such as megestrol acetate, dexamethasone, and methylprednisolone, is creating a positive market outlook. Moreover, the increasing number of hospitals and healthcare centers, coupled with significant technological advancements in the healthcare industry, is propelling the growth of the market. Request for a free sample report: https://www.imarcgroup.com/cancer-cachexia- market/requestsample

5. Report Description Report Description and Highlights Market Summary: Breakup by Therapeutics: • • • • Progestogens Corticosteroids Combination Therapy Others Breakup by Mode of Action: • • Appetite Stimulators Weight Loss Stabilizers

6. Report Description Report Description and Highlights Breakup by Distribution Channel: • • • Hospital Stores Retail Pharmacy Online Pharmacy Breakup by Region: • • • • • North America Europe Asia Pacific Middle East and Africa Latin America On account of the aforementioned factors, the market is anticipated to witness strong growth during 2023-2028.

7. Report Description Report Description and Highlights Competitive Landscape With Key player: • • • • • • • • • • • AAVogen Inc. Actimed Therapeutics Ltd. Aphios Corporation Artelo Biosciences Inc. AVEO Pharmaceuticals Inc. Fresenius Kabi AG Helsinn Healthcare SA Merck & Co. Inc. NGM Biopharmaceuticals Inc. Pfizer Inc. Tetra Bio-Pharma View Report TOC, Figures and Tables: https://www.imarcgroup.com/cancer-cachexia-market

8. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

10. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

11. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com